Influenza vaccines | Tenderlake

Influenza vaccines

Contract Value:
NOK 784M - 784M
Notice Type:
Contract Notice
Published Date:
23 September 2022
Closing Date:
20 October 2022
Location(s):
NO NORGE (NO Norway/NORGE)
Description:
Four valent vaccination against seasonal influenza

Folkehelseinstituttet [the Norwegian Institute of Public Health] is holding an open tender contest with the aim of ensuring sufficient delivery of four valent vaccine against seasonal influenza (ATC code J07B B02) for vaccination of persons in defined risk and target groups (see the tender documentation point 1.4) for the 2023/2024 and 2024/2025 seasons, with an option for a further two seasons.

The contest is being held electronically in the CTM KGV and information given in the tender management tool, in the prior information notice and the tender documentation stipulate the rules and terms for the contest.

According to the Tender documentation, chapter 6 "Award criteria" are the contest award criteria Price 70% and Quality - Technical characteristics 30%. The tender documentation has several minimum requirements for the vaccine. All the minimum requirements must be fulfilled. NIPH aims to award two partial contracts for 60% and 40% of the total contract volume.


Four valent vaccines against seasonal influenza 60%

Folkehelseinstituttet [the Norwegian Institute of Public Health] is holding an open tender contest with the aim of ensuring sufficient delivery of four valent vaccine against seasonal influenza (ATC code J07B B02) for vaccination of persons in defined risk and target groups (see the tender documentation point 1.4) for the 2023/2024 and 2024/2025 seasons, with an option for a further two seasons.

The contest is being held electronically in the CTM KGV and information given in the tender management tool, in the prior information notice and the tender documentation stipulate the rules and terms for the contest.

According to the Tender documentation, chapter 6 "Award criteria" are the contest award criteria Price 70% and Quality - Technical characteristics 30%. The tender documentation has several minimum requirements for the vaccine. All the minimum requirements must be fulfilled. NIPH aims to award two partial contracts for 60% and 40% of the total contract volume.


Four valent vaccines against seasonal influenza 40%

Folkehelseinstituttet [the Norwegian Institute of Public Health] is holding an open tender contest with the aim of ensuring sufficient delivery of four valent vaccine against seasonal influenza (ATC code J07B B02) for vaccination of persons in defined risk and target groups (see the tender documentation point 1.4) for the 2023/2024 and 2024/2025 seasons, with an option for a further two seasons.

The contest is being held electronically in the CTM KGV and information given in the tender management tool, in the prior information notice and the tender documentation stipulate the rules and terms for the contest.

According to the Tender documentation, chapter 6 "Award criteria" are the contest award criteria Price 70% and Quality - Technical characteristics 30%. The tender documentation has several minimum requirements for the vaccine. All the minimum requirements must be fulfilled. NIPH aims to award two partial contracts for 60% and 40% of the total contract volume.

Download full details as .pdf
The Buyer:
Folkehelseinstituttet
CPV Code(s):
33651600 - Vaccines
33651660 - Influenza vaccines